Twinuro 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Medix Pharmaceutical Co., Ltd.
MFDS item code 201901408 · Approved 2019.03.08
This product's status changed to Expired on 2024.03.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled by monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with amlodipine or telmisartan monotherapy. Essential hypertension causes persistent elevation of blood pressure, increasing the risk of cardiovascular complications, thus effective blood pressure control is very important. This drug helps to lower blood pressure steadily for hypertension management. In cases where monotherapy is difficult, combination therapy can offer more effective blood pressure control. Therefore, this medication is used to treat essential hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with the individual components as described below, switching directly to this medication may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medication 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medication 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section “3. Patients requiring caution in administration.”) In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.
Use of this medication is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.
This medication should not be used during pregnancy, especially during the second and third trimesters, as it can cause serious harm to the fetus. This drug should not be administered to women who are pregnant or breastfeeding, patients with severe liver or biliary problems, patients with severely reduced heart function, or those with hypersensitivity to its components. Patients with primary aldosteronism, certain heart valve diseases, impaired liver function, or gastrointestinal diseases should use this medication with special caution. Side effects such as dizziness or edema may occur frequently; if symptoms are severe, consultation with a doctor is advised. There is a possibility that blood pressure may drop excessively, particularly in patients with dehydration or low sodium levels, so it is important to check the condition before taking the medication and follow the doctor's instructions. This medication may increase potassium levels, so patients at risk for hyperkalemia should have regular blood tests to monitor potassium levels. Patients with impaired kidney function should periodically check kidney function and electrolyte status while taking this medication. Patients with heart disease or heart failure should be especially cautious when taking this medication and should inform the doctor immediately if symptoms worsen. This medication may cause drowsiness or dizziness while driving or operating machinery, so caution is necessary while taking it. There may be interactions with other medications, so if currently taking other medicines, it is important to inform the doctor or pharmacist. This drug is not recommended for children, and dosage adjustments may be necessary for the elderly. In the event of overdose, symptoms such as decreased blood pressure, dizziness, or heart rhythm disturbances may occur; if any abnormal symptoms arise, immediate medical attention should be sought. When storing, keep out of reach of children and do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that shields it from light, maintaining a storage temperature between 1 and 30 degrees Celsius. This will help preserve the drug's effectiveness and safety.
Biconvex oval-shaped film-coated tablets in white and light gray
30 tablets/box[(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Medix Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.